Video

How Can Pharmacists Bolster Immunization and Travel Health Programs?

Jeffrey Goad, PharmD, MPH, FAPhA, offers advice for pharmacists looking to bolster their immunization and travel health programs.

Jeffrey Goad, PharmD, MPH, FAPhA, offers advice for pharmacists looking to bolster their immunization and travel health programs.

This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.

Related Videos
Lipoprotein particles | Image Credit: © komgritch - stock.adobe.com
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
Senior Doctor is examining An Asian patient.
Related Content
Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events
December 2nd 2024

Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events

Stuart Long
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

PREP Act, COVID-19, Pandemic, Pharmacy, Immunization | Image Credit: ©dusanpetkovic1 | stock.adobe.com
December 2nd 2024

Looming PREP Act Expiration Could Impact Health Care Access for Rural Patients

Ashley Gallagher, Associate Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
FDA Approval, Ustekinumab, Stelera, Crohn disease, Plaque Psoriasis, Psoriatic Arthritis | Image Credit: © Araki Illustrations | stock.adobe.com
Published: December 2nd 2024 | Updated: December 2nd 2024

FDA Approves Ustekinumab-kfce as Sixth Biosimilar to Stelara

Ashley Gallagher, Associate Editor
Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs Syndrome
December 1st 2024

Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs Syndrome

Kamila Dymala, PharmD, RPh, MBA, BCMTM, PACS